Cargando…
Cell-type-specific alternative polyadenylation as a therapeutic biomarker in lung cancer progression
Autores principales: | Li, Kang, Qiang, Min, Xu, Yungang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10520420/ https://www.ncbi.nlm.nih.gov/pubmed/37766793 http://dx.doi.org/10.1016/j.omtn.2023.102030 |
Ejemplares similares
-
Alternative polyadenylation: An untapped source for prostate cancer biomarkers and therapeutic targets?
por: Kurozumi, Akira, et al.
Publicado: (2021) -
Cell-type-specific alternative polyadenylation promotes oncogenic gene expression in non-small cell lung cancer progression
por: Huang, Kexin, et al.
Publicado: (2023) -
Cleavage and Polyadenylation Specific Factor 1 Promotes Tumor Progression via Alternative Polyadenylation and Splicing in Hepatocellular Carcinoma
por: Chen, Shi-lu, et al.
Publicado: (2021) -
Infernape uncovers cell type–specific and spatially resolved alternative polyadenylation in the brain
por: Kang, Bowei, et al.
Publicado: (2023) -
Diverse cell-specific patterns of alternative polyadenylation in Drosophila
por: Lee, Seungjae, et al.
Publicado: (2022)